As a company with an audit and supervisory board, the composition ratio of outside directors is high, and we have established an advanced management system for a startup company.
Experienced all the necessary elements for a start-up under a global environment, such as basic research in academia, clinical development at listed pharmaceutical companies in Japan and overseas, medical affairs, sales marketing and management prior to establishing Human Life CORD Co., Ltd.
Invited Teaching Staff Part-time Lecturer) at the Aging Research Field, Graduate School of Medical Science, Nagoya University
The leaders with strengths in each function required for the commercialization of regenerative medicine and other products are united in promoting the business.
Targeting therapy for intractable leukemia was studied as a researcher of the former Ministry of International Trade and Industry Institute of Industrial Science and Technology, and international results were obtained.
Experienced in the three elements necessary for the drug discovery bio start-up (basic research experience in academia/general administration of clinical development at a pharmaceutical company/management in bioventures) and global business experience.
Founded Human Life CORD Japan Inc. in April 2017, President and Representative Director
Experienced pharma professional with a track record of new drug development, launches and life cycle management in specialty care area such as oncology, autoimmune diseases and retinal diseases, as well as leadership experiences at global companies.
After working in corporate financing at domestic and overseas branches of commercial banks, he worked at a non-life insurance venture capital firm, investing in and supporting technology startups mainly in the life sciences. After that, he became independent and provided support for planning and implementing business plans and strategies for startups. He has been involved in numerous financing, M&A, and business partnership projects from direction to operations, leading to successful deals. He has been continuously involved in Human Life CORD as an advisor and outside director since founding, and later joined as a leadership member.
Joined our team after experience at a foreign consulting firm, and supporting and investing in ventures in the fields of life sciences and healthcare.
In management consulting, he leads new businesses for major Japanese and overseas pharmaceutical and medical device companies, R&D, support for formulation and execution of organizational strategies, and various business reform projects.
In support of ventures, the company provides end-to-end support for Japanese business development activities of over 20 drug discovery ventures from Europe and the U.S.
Joined our team after holding leadership roles in basic research, clinical development, and medical affairs for rare disease drug development at both Japanese and global pharmaceutical companies. Leveraging his extensive experience, he now drives the company’s cell therapy portfolio in alignment with its global strategy, aiming to deliver new value to patients.